Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed

Summary

The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity (U2F mechanism) for the development and maintenance of Human and Animal Food Rapid Response Teams. Clinical trials are explicitly not allowed under this award. The opportunity is in a forecasted/pre-solicitation stage as of late November 2023, meaning full details and requirements have not yet been published.

What they want

Risks & flags

• Forecasted notice only — extremely limited scope detail available, making it impossible to assess competitive fairness at this stage
• No award value, eligibility criteria, or submission requirements disclosed